Stock FME FRESENIUS MEDICAL CARE AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials Fresenius Medical Care AG Deutsche Boerse AG

Equities

FME

DE0005785802

Healthcare Facilities & Services

Market Closed - Deutsche Boerse AG
Other stock markets
 03:30:56 2024-04-26 pm EDT 		5-day change 1st Jan Change
37.4 EUR -2.48% Intraday chart for Fresenius Medical Care AG +1.99% -1.37%
Apr. 26 FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from Jefferies ZD
Apr. 24 European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 19,672 19,974 16,742 8,970 11,138 10,980 - -
Enterprise Value (EV) 1 32,447 31,272 28,580 20,909 21,898 20,839 20,204 19,316
P/E ratio 16.7 x 17.2 x 17.3 x 13.3 x 22.3 x 15.5 x 11.4 x 9.73 x
Yield 1.82% 1.96% 2.36% 3.66% 3.13% 2.91% 3.49% 4.15%
Capitalization / Revenue 1.13 x 1.12 x 0.95 x 0.46 x 0.57 x 0.56 x 0.54 x 0.52 x
EV / Revenue 1.86 x 1.75 x 1.62 x 1.08 x 1.13 x 1.06 x 0.99 x 0.91 x
EV / EBITDA 8.4 x 7.65 x 8.22 x 6.24 x 7.02 x 6.19 x 5.45 x 4.98 x
EV / FCF 22.5 x 9.78 x 17.2 x 14.1 x 11.2 x 11.7 x 10.6 x 12.9 x
FCF Yield 4.44% 10.2% 5.81% 7.08% 8.95% 8.56% 9.46% 7.77%
Price to Book 1.67 x 1.78 x 1.32 x 0.64 x 0.75 x 0.78 x 0.74 x 0.72 x
Nbr of stocks (in thousands) 298,249 292,869 292,994 293,413 293,413 293,413 - -
Reference price 2 65.96 68.20 57.14 30.57 37.96 37.42 37.42 37.42
Announcement Date 2/20/20 2/23/21 2/22/22 2/21/23 2/20/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 17,477 17,859 17,619 19,398 19,454 19,649 20,362 21,300
EBITDA 1 3,863 4,090 3,476 3,350 3,121 3,366 3,706 3,880
EBIT 1 2,270 2,304 1,852 1,512 1,369 1,700 2,045 2,342
Operating Margin 12.99% 12.9% 10.51% 7.79% 7.04% 8.65% 10.04% 11%
Earnings before Tax (EBT) 1 1,841 1,936 1,572 1,219 1,033 1,276 1,628 1,947
Net income 1 1,200 1,164 969.3 673.4 499 710.7 972.5 1,191
Net margin 6.87% 6.52% 5.5% 3.47% 2.57% 3.62% 4.78% 5.59%
EPS 2 3.960 3.960 3.310 2.300 1.700 2.411 3.295 3.844
Free Cash Flow 1 1,442 3,197 1,660 1,480 1,960 1,783 1,911 1,501
FCF margin 8.25% 17.9% 9.42% 7.63% 10.08% 9.07% 9.39% 7.05%
FCF Conversion (EBITDA) 37.33% 78.17% 47.76% 44.18% 62.8% 52.97% 51.56% 38.69%
FCF Conversion (Net income) 120.18% 274.57% 171.26% 219.78% 392.79% 250.87% 196.51% 126.04%
Dividend per Share 2 1.200 1.340 1.350 1.120 1.190 1.090 1.307 1.554
Announcement Date 2/20/20 2/23/21 2/22/22 2/21/23 2/20/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 4,441 4,647 4,548 4,757 5,096 4,997 4,704 4,825 4,936 4,988 4,698 4,799 4,948 5,028 -
EBITDA 1 907.5 895.4 767 763 973.6 846.6 698.8 790.8 778.3 854 759.9 855.4 898 766.6 -
EBIT 1 504.7 449.2 348 341 471.6 351.9 260.9 357 324 428 350.2 427 461.4 496.2 -
Operating Margin 11.36% 9.67% 7.65% 7.17% 9.25% 7.04% 5.55% 7.4% 6.56% 8.58% 7.45% 8.9% 9.33% 9.87% -
Earnings before Tax (EBT) 436.2 382.4 278.6 268.9 395.2 - - - - - - - - - -
Net income 1 273 228.7 157 147 230.1 138.8 86.36 140 84 188 13 - - - -
Net margin 6.15% 4.92% 3.45% 3.09% 4.52% 2.78% 1.84% 2.9% 1.7% 3.77% 0.28% - - - -
EPS 2 0.9300 0.7800 0.5400 0.5000 0.7800 0.4800 0.2900 0.4800 0.2900 0.6400 0.0400 - - - -
Dividend per Share 2 - 1.350 - - - 1.120 - - - 1.190 - - - 0.7387 -
Announcement Date 11/2/21 2/22/22 5/4/22 7/28/22 10/31/22 2/21/23 5/9/23 8/2/23 11/1/23 2/20/24 - - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 12,775 11,298 11,838 11,939 10,760 9,859 9,225 8,337
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.307 x 2.762 x 3.406 x 3.564 x 3.448 x 2.929 x 2.489 x 2.149 x
Free Cash Flow 1 1,442 3,197 1,660 1,480 1,960 1,783 1,911 1,501
ROE (net income / shareholders' equity) 11.5% 11.7% 7.37% 5.05% 4.99% 5.65% 6.81% 7.43%
ROA (Net income/ Total Assets) 4.06% 3.6% 2.93% 1.92% 2.17% 2.09% 2.76% 3.51%
Assets 1 29,589 32,308 33,038 35,060 22,998 34,028 35,186 33,979
Book Value Per Share 2 39.50 38.30 43.30 47.70 50.50 48.30 50.40 51.90
Cash Flow per Share 2 8.480 14.40 8.500 7.390 8.960 8.010 8.350 9.150
Capex 1 1,125 1,036 829 687 669 871 945 1,052
Capex / Sales 6.44% 5.8% 4.71% 3.54% 3.44% 4.43% 4.64% 4.94%
Announcement Date 2/20/20 2/23/21 2/22/22 2/21/23 2/20/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
37.42 EUR
Average target price
39.01 EUR
Spread / Average Target
+4.24%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
DAVITA INC. Stock DaVita Inc.
+27.44% 11.71B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-3.97% 11.66B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. FME Stock
  4. FME Stock
  5. Financials Fresenius Medical Care AG